Provided by Tiger Trade Technology Pte. Ltd.

Therapeutics

4.23
0.0000
Volume:77.72K
Turnover:328.39K
Market Cap:132.36M
PE:-1.02
High:4.28
Open:4.23
Low:4.17
Close:4.23
52wk High:50.40
52wk Low:4.17
Shares:31.29M
Float Shares:18.39M
Volume Ratio:1.53
T/O Rate:0.42%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.1300
EPS(LYR):-2.8503
ROE:-59.21%
ROA:-37.36%
PB:0.60
PE(LYR):-1.48

Loading ...

PYC Therapeutics Says First Patient Dosed in Open-Label Extension of Drug Candidate Study in Polycystic Kidney Disease

MT Newswires Live
·
Sep 11

Cardiol Therapeutics Files US$150 Million Preliminary Base Shelf Prospectus After OSC Review

TIPRANKS
·
Sep 11

Whitehawk Therapeutics Adds Oncology Leader to Board

TIPRANKS
·
Sep 11

Cardiol Therapeutics files $150M preliminary base shelf prospectus

TIPRANKS
·
Sep 11

Press Release: Whitehawk Therapeutics Appoints Vijay Iyengar, MD, to Board of Directors

Dow Jones
·
Sep 11

Serina Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference

GlobeNewswire
·
Sep 11

Private Markets: Gimlet Labs, Encoded Therapeutics secure new funding

TIPRANKS
·
Sep 11

Kazia Therapeutics Price Target Maintained with a $40.00/Share by BTIG

Dow Jones
·
Sep 10

Aprea Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference

GlobeNewswire
·
Sep 10

CAMP4 Therapeutics Receives Authorization in the United Kingdom for Phase 1/2 Human Clinical Trial of CMP-002 in Patients with SYNGAP1-Related Disorder

GlobeNewswire
·
Sep 10

Indaptus Therapeutics Announces Private Equity Financing Deal

TIPRANKS
·
Sep 10

Neurizon Therapeutics Redeems 1 Million Convertible Notes From Obsidian for Over $1 Million; Shares Fall 8%

MT Newswires Live
·
Sep 10

Top Executive Makes Eye-Catching Move at Denali Therapeutics

TIPRANKS
·
Sep 10

Cathie Wood’s ARK Investment buys 271K shares of Beam Therapeutics today

TIPRANKS
·
Sep 10

Summit Therapeutics Raised to Buy from Hold by Jefferies

Dow Jones
·
Sep 10

Rallybio CFO Transition Amid Pending Avenzo Therapeutics Merger

TIPRANKS
·
Sep 10

NeuroSense Therapeutics to Enact 1-for-20 Reverse Share Split on Nasdaq

TIPRANKS
·
Sep 10

Oruka Therapeutics to Attend the 2026 Morgan Stanley Global Healthcare Conference

GlobeNewswire
·
Sep 10

Obsidian Therapeutics participates in a conference call with William Blair

TIPRANKS
·
Sep 10

Summit Therapeutics Shares Rise After Upgrade From Jefferies

MT Newswires Live
·
Sep 10